AUGX logo

Augmedix, Inc. Stock Price

NasdaqCM:AUGX Community·US$116.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

AUGX Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

AUGX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet slight.

4 Risks
1 Reward

Augmedix, Inc. Key Details

US$51.6m

Revenue

US$26.7m

Cost of Revenue

US$24.9m

Gross Profit

US$48.7m

Other Expenses

-US$23.8m

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-0.48
48.22%
-46.23%
196.1%
View Full Analysis

About AUGX

Founded
2013
Employees
1430
CEO
Emmanuel Krakaris
WebsiteView website
www.augmedix.com

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient’s health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020. The company was founded in 2013 and is headquartered in San Francisco, California.

Recent AUGX News & Updates

Recent updates

No updates